Vivani Medical
VANI
39 hedge funds and large institutions have $12M invested in Vivani Medical in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 9 closing their positions.
1,206% more call options, than puts
Call options by funds: $705K | Put options by funds: $54K
0% more funds holding
Funds holding: 39 → 39 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
0.04% less ownership
Funds ownership: 0.5% → 0.45% (-0.04%)
12% less capital invested
Capital invested by funds: $13.7M → $12M (-$1.67M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$185K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$133K |
| 3 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$57.6K |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$44.4K |
| 5 |
BlackRock
New York
|
+$39K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$98K |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$96.3K |
| 3 |
VF
Virtu Financial
New York
|
-$84K |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$20K |
| 5 |
Morgan Stanley
New York
|
-$15.2K |
VANI Hedge Fund Activity: Q2 2018 in Review
39 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2018, worth a combined $12M — down 12% from $13.7M a quarter earlier.
Fund positioning in VANI was balanced in Q2 2018: 9 funds opened new positions, 9 closed out, 6 added to existing stakes and 9 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $185K. The largest seller was Oracle Investment Management, exiting entirely with an estimated $98K sold.
- 39 institutional investors held Vivani Medical (VANI) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $12M of Vivani Medical stock for Q2 2018, down 12% quarter-over-quarter.
- 9 funds opened new Vivani Medical positions in Q2 2018 and 9 closed out, a net change of 0 holders.
- The largest Vivani Medical buyer in Q2 2018 was JP Morgan Chase, an estimated $185K added.
- The largest Vivani Medical seller in Q2 2018 was Oracle Investment Management, an estimated $98K sold.
Based on aggregated 13F filings for Q2 2018.